A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists

被引：0
|
作者：
Cassandra M. Townsend
Reena Khanna
Aze Suzanne Wilson
机构：
[1] Western University,Division of Gastroenterology, Department of Medicine
[2] Western University,Division of Clinical Pharmacology, Department of Medicine
[3] Western University,Department of Physiology and Pharmacology
来源：
Digestive Diseases and Sciences | 2021年 / 66卷
关键词：
Ulcerative colitis; Crohn’s disease; Inflammatory bowel disease; Tumor necrosis factor-; antagonists; Non-melanoma skin cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4436 / 4440
页数：4
相关论文
共 50 条
  • [1] A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-α Antagonists
    Townsend, Cassandra M.
    Khanna, Reena
    Wilson, Aze Suzanne
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (12) : 4436 - 4440
  • [2] Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
    Long, Millie D.
    Herfarth, Hans H.
    Pipkin, Clare A.
    Porter, Carol Q.
    Sandler, Robert S.
    Kappelman, Michael D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2010, 8 (03) : 268 - 274
  • [3] Association Between Tumor Necrosis Factor-α Antagonists and Risk of Cancer in Patients With Inflammatory Bowel Disease
    Andersen, Nynne Nyboe
    Pasternak, Bjorn
    Basit, Saima
    Andersson, Mikael
    Svanstrom, Henrik
    Caspersen, Sarah
    Munkholm, Pia
    Hviid, Anders
    Jess, Tine
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (23): : 2406 - 2413
  • [4] Melanoma and non-Melanoma Skin Cancer in Inflammatory Bowel Disease Patients following Tumor Necrosis Factor-α Inhibitor Monotherapy and in Combination with Thiopurines: Analysis of the Food and Drug Administration Adverse Event Reporting System
    McKenna, Michael R.
    Stobaugh, Derrick J.
    Deepak, Parakkal
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2014, 23 (03) : 267 - 271
  • [5] Drug insight:: Antagonists of tumor-necrosis factor-α in the treatment of inflammatory bowel disease
    Chang, JT
    Lichtenstein, GR
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (04): : 220 - 228
  • [6] The risk of non-melanoma skin cancer in New Zealand in inflammatory bowel disease patients treated with thiopurines
    Bahi, Morwan
    Walmsley, Russell S.
    Gray, Andrew R.
    Young, David
    Hobbs, Catherine E.
    Aluzaite, Kristina
    Schultz, Michael
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (05) : 1047 - 1052
  • [7] Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease
    Ordas, Ingrid
    Feagan, Brian G.
    Sandborn, William J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (10) : 1079 - 1087
  • [8] Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update
    Leso, Veruscka
    Leggio, Lorenzo
    Armuzzi, Alessandro
    Gasbarrini, Giovanni
    Gasbarrini, Antonio
    Addolorato, Giovanni
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (07) : 779 - 786
  • [9] Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease
    Gareb, Bahez
    Otten, Antonius T.
    Frijlink, Henderik W.
    Dijkstra, Gerard
    Kosterink, Jos G. W.
    PHARMACEUTICS, 2020, 12 (06) : 1 - 31
  • [10] Erythema nodosum, malignant melanoma and non-melanoma skin cancer in relation to inflammatory bowel disease: a Mendelian randomization study
    Zhao, Yang
    Shao, Yifan
    Zhou, Jing
    Pei, Jianing
    Chong, Jinchen
    Lu, Changye
    Chen, Yugen
    SCIENTIFIC REPORTS, 2025, 15 (01):
12345